Literature DB >> 2522457

Correlations between heparan sulfate metabolism and hepatoma growth.

M Ishihara1, H E Conrad.   

Abstract

A rat hepatoma cell line (Gershenson et al., Science, 170:859-861, 1970) contains a dynamic steady-state pool of free heparan sulfate (HS) chains in the nucleus that increases in amount when growing cells reach confluence (Fedarko and Conrad, J. Cell Biol., 102:587-599, 1986). In logarithmically growing cells labeled with 35SO4(2-) steady-state levels of [35SO4]HS in the nucleus are altered by a variety of culture conditions. Rapidly dividing cells (doubling time = 18-22 h) growing under optimized conditions had steady-state levels of nuclear HS within the range of 40-50 pmol 35SO4 in nuclear HS/10(6) cells. The steady-state levels of nuclear HS were lowered by several changes in culture conditions, including 1) additions of 1 mM p-nitrophenyl-beta-D-xyloside, 0.25-0.5 mM (+)-catechin, 0.5 ng/ml transforming growth factor beta, 20 ng/ml phorbol-12-myristate-13-acetate, 1 mM dibutyryl cAMP, or 1 mM inositol-2-PO4; 2) decreased levels of D-glucose; or 3) deletions of serum, insulin, or inositol. In all cases lowering of the nuclear HS level was accompanied by an increase in the cell doubling times, suggesting a correlation in which nuclear HS levels must be optimized for maximal growth rates. When cells cultured under optimal growth conditions reached confluence, the level of nuclear HS increased threefold and the cells stopped dividing. The same culture conditions that lowered the steady-state levels of HS in the logarithmically growing cells prevented this rise in the nuclear HS as the cells reached confluence and resulted in loss of contact inhibition and overgrowth of the confluent cultures. These observations suggest a second correlation in which elevated nuclear HS levels are found when cell growth is inhibited at confluence; prevention of this rise results in continued growth. Consistent with this correlation between elevated nuclear HS and reduced growth rates, it was observed that addition of either 0.5 microgram/ml hydrocortisone or 0.05 microgram/ml retinoic acid to the culture medium of logarithmically growing cultures resulted in increases in steady-state levels of nuclear HS that were accompanied by increased cell doubling times. The two agents that increased the levels of nuclear HS in logarithmically growing cultures had little effect on levels of nuclear HS in confluent cells or on contact inhibition.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522457     DOI: 10.1002/jcp.1041380305

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  The heparin-binding lectin from ovine placenta: purification and identification as histone H4.

Authors:  A L Ambrosio; M M Iglesias; C Wolfenstein-Todel
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

2.  Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.

Authors:  J Dudás; G Ramadori; T Knittel; K Neubauer; D Raddatz; K Egedy; I Kovalszky
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

3.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  Inhibition of histone acetyltransferase by glycosaminoglycans.

Authors:  Jo Ann Buczek-Thomas; Edward Hsia; Celeste B Rich; Judith A Foster; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

5.  Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.

Authors:  M Lyon; J T Gallagher
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

6.  Cell surface heparan sulfate proteoglycan and chondroitin sulfate proteoglycan of arterial smooth muscle cells.

Authors:  I J Edwards; W D Wagner
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

7.  Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.

Authors:  H Habuchi; S Suzuki; T Saito; T Tamura; T Harada; K Yoshida; K Kimata
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

Review 8.  What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.

Authors:  Anthony J Hayes; James Melrose
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

9.  Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.

Authors:  Fang Zong; Eleni Fthenou; Nina Wolmer; Péter Hollósi; Ilona Kovalszky; László Szilák; Carolin Mogler; Gustav Nilsonne; Georgios Tzanakakis; Katalin Dobra
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

10.  Polyamines release the let-7b-mediated suppression of initiation codon recognition during the protein synthesis of EXT2.

Authors:  Masataka Imamura; Kyohei Higashi; Katsutoshi Yamaguchi; Kiryu Asakura; Tomomi Furihata; Yusuke Terui; Toshihiko Satake; Jiro Maegawa; Kazunori Yasumura; Ai Ibuki; Tomoko Akase; Kazuhiro Nishimura; Keiko Kashiwagi; Robert J Linhardt; Kazuei Igarashi; Toshihiko Toida
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.